• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过两段式自循环工艺在生物反应器中大规模生产噬菌体 Φ CS01。

Large-Scale Production of Bacteriophage Φ CS01 in Bioreactors via a Two-Stage Self-Cycling Process.

机构信息

Department of Biological Science and Technology, Yonsei University, Wonju 26493, Republic of Korea.

出版信息

J Microbiol Biotechnol. 2021 Oct 28;31(10):1430-1437. doi: 10.4014/jmb.2107.07017.

DOI:10.4014/jmb.2107.07017
PMID:34489375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9705936/
Abstract

is an opportunistic pathogenic bacterium found in powdered infant formula and is fatal to neonates. Antibiotic resistance has emerged owing to overuse of antibiotics. Therefore, demand for high-yield bacteriophages as an alternative to antibiotics has increased. Accordingly, we developed a modified mass-production method for bacteriophages by introducing a two-stage self-cycling (TSSC) process, which yielded high-concentration bacteriophage solutions by replenishing the nutritional medium at the beginning of each process, without additional challenge. pH of the culture medium was monitored in real-time during growth and bacteriophage CS01 propagation, and the changes in various parameters were assessed. The pH of the culture medium dropped to 5.8 when the host bacteria reached the early log phase (OD = 0.3). After challenge, it decreased to 4.65 and then recovered to 4.94; therefore, we set the optimum pH to challenge the phage at 5.8 and that to harvest the phage at 4.94. We then compared phage production during the TSSC process in jar-type bioreactors and the batch culture process in shaker flasks. In the same volume of LB medium, the concentration of the phage titer solution obtained with the TSSC process was 24 times higher than that obtained with the batch culture process. Moreover, we stably obtained high concentrations of bacteriophage solutions for three cycles with the TSSC process. Overall, this modified TSSC process could simplify large-scale production of bacteriophage CS01 and reduce the unit cost of phage titer solution. These results could contribute to curing infants infected with antibiotic-resistant .

摘要

是一种机会致病菌,存在于配方奶粉中,对新生儿是致命的。由于抗生素的过度使用,出现了抗生素耐药性。因此,对抗生素替代品——高产量噬菌体的需求增加了。因此,我们通过引入两段式自我循环(TSSC)工艺,开发了一种改良的噬菌体大规模生产方法,在每个工艺开始时补充营养培养基,而无需额外的挑战,从而产生高浓度的噬菌体溶液。在噬菌体 CS01 的生长和繁殖过程中,实时监测培养基的 pH 值,并评估各种参数的变化。当宿主细菌进入早期对数期(OD = 0.3)时,培养基的 pH 值下降到 5.8。挑战后,它下降到 4.65,然后恢复到 4.94;因此,我们将最佳 pH 值设定为 5.8 以挑战噬菌体,将收获噬菌体的 pH 值设定为 4.94。然后,我们比较了 TSSC 工艺在罐式生物反应器和摇瓶分批培养工艺中的噬菌体生产情况。在相同体积的 LB 培养基中,TSSC 工艺获得的噬菌体效价溶液的浓度比分批培养工艺高 24 倍。此外,我们使用 TSSC 工艺稳定地获得了三个循环的高浓度噬菌体溶液。总的来说,这种改良的 TSSC 工艺可以简化噬菌体 CS01 的大规模生产,并降低噬菌体效价溶液的单位成本。这些结果可能有助于治愈感染抗生素耐药性的婴儿。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/cdf77f7ed50a/jmb-31-10-1430-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/c402389ca911/jmb-31-10-1430-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/5ef166541c93/jmb-31-10-1430-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/a2c0574222b4/jmb-31-10-1430-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/2e76d8f33d25/jmb-31-10-1430-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/1c74f0073843/jmb-31-10-1430-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/f3044528cff0/jmb-31-10-1430-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/0c5253fef362/jmb-31-10-1430-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/cdf77f7ed50a/jmb-31-10-1430-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/c402389ca911/jmb-31-10-1430-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/5ef166541c93/jmb-31-10-1430-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/a2c0574222b4/jmb-31-10-1430-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/2e76d8f33d25/jmb-31-10-1430-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/1c74f0073843/jmb-31-10-1430-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/f3044528cff0/jmb-31-10-1430-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/0c5253fef362/jmb-31-10-1430-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9d/9705936/cdf77f7ed50a/jmb-31-10-1430-f8.jpg

相似文献

1
Large-Scale Production of Bacteriophage Φ CS01 in Bioreactors via a Two-Stage Self-Cycling Process.通过两段式自循环工艺在生物反应器中大规模生产噬菌体 Φ CS01。
J Microbiol Biotechnol. 2021 Oct 28;31(10):1430-1437. doi: 10.4014/jmb.2107.07017.
2
Investigating the biocontrol and anti-biofilm potential of a three phage cocktail against Cronobacter sakazakii in different brands of infant formula.研究三种噬菌体鸡尾酒对不同品牌婴儿配方奶粉中阪崎克罗诺杆菌的生物防治和抗生物膜潜力。
Int J Food Microbiol. 2017 Jul 17;253:1-11. doi: 10.1016/j.ijfoodmicro.2017.04.009. Epub 2017 Apr 21.
3
Evaluation of the biocontrol potential of a collagen peptide/trehalose-based Cronobacter sakazakii phage powder in rehydrated powdered infant formula.评价胶原蛋白肽/海藻糖基阪崎克罗诺杆菌噬菌体干粉对复水婴儿配方粉的生物防治潜力。
Food Res Int. 2023 Nov;173(Pt 1):113257. doi: 10.1016/j.foodres.2023.113257. Epub 2023 Jul 8.
4
A Novel Bacteriophage Targeting Cronobacter sakazakii Is a Potential Biocontrol Agent in Foods.一种靶向阪崎肠杆菌的新型噬菌体是食品中潜在的生物防治剂。
Appl Environ Microbiol. 2015 Oct 23;82(1):192-201. doi: 10.1128/AEM.01827-15. Print 2016 Jan 1.
5
Efficiency of bacteriophage therapy against Cronobacter sakazakii in Galleria mellonella (greater wax moth) larvae.噬菌体治疗对蜡螟幼虫(大蜡螟)中阪崎克罗诺杆菌的疗效。
Arch Virol. 2014 Sep;159(9):2253-61. doi: 10.1007/s00705-014-2055-x. Epub 2014 Apr 6.
6
Characterization and Genomic Analysis of Novel Bacteriophage ΦCS01 Targeting .新型噬菌体ΦCS01靶向性的表征与基因组分析
J Microbiol Biotechnol. 2019 May 28;29(5):696-703. doi: 10.4014/jmb.1812.12054.
7
Complete genome sequence of Cronobacter sakazakii bacteriophage CR3.阪崎克罗诺杆菌噬菌体 CR3 的全基因组序列
J Virol. 2012 Jun;86(11):6367-8. doi: 10.1128/JVI.00636-12.
8
The application of bacteriophage to control planktonic and biofilm growth in infant formula milk.噬菌体在控制婴儿配方奶粉中浮游生物和生物膜生长中的应用。
Biofouling. 2021 Jul;37(6):606-614. doi: 10.1080/08927014.2021.1943741. Epub 2021 Jun 30.
9
Application of a novel phage LPCS28 for biological control of Cronobacter sakazakii in milk and reconstituted powdered infant formula.新型噬菌体 LPCS28 在牛奶和还原乳婴儿配方粉中防控阪崎克罗诺杆菌的应用。
Food Res Int. 2023 Oct;172:113214. doi: 10.1016/j.foodres.2023.113214. Epub 2023 Jun 30.
10
Isolation and characterization of new phage vB_CtuP_A24 and application to control Cronobacter spp. in infant milk formula and lettuce.新型噬菌体 vB_CtuP_A24 的分离与鉴定及其在婴幼儿配方奶粉和生菜中控制克罗诺杆菌属的应用。
Food Res Int. 2021 Mar;141:110109. doi: 10.1016/j.foodres.2021.110109. Epub 2021 Jan 12.

引用本文的文献

1
Modeling and Dynamic Parameterized Predictive Control of Dissolved Oxygen in Dual-Tank Bioreactor Systems.双罐生物反应器系统中溶解氧的建模与动态参数化预测控制
Bioengineering (Basel). 2025 Jun 24;12(7):690. doi: 10.3390/bioengineering12070690.
2
Bridging the gap: Phage manufacturing processes from laboratory to agri-food industry.弥合差距:从实验室到农业食品行业的噬菌体生产工艺
Virus Res. 2025 Mar;353:199537. doi: 10.1016/j.virusres.2025.199537. Epub 2025 Jan 31.

本文引用的文献

1
How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections.噬菌体如何应对临床感染中耐药细菌带来的挑战。
Infect Drug Resist. 2020 Jan 7;13:45-61. doi: 10.2147/IDR.S234353. eCollection 2020.
2
Characterization and Genomic Analysis of Novel Bacteriophage ΦCS01 Targeting .新型噬菌体ΦCS01靶向性的表征与基因组分析
J Microbiol Biotechnol. 2019 May 28;29(5):696-703. doi: 10.4014/jmb.1812.12054.
3
Applications of Bacteriophages in the Treatment of Localized Infections in Humans.噬菌体在人类局部感染治疗中的应用。
Front Microbiol. 2018 Aug 2;9:1696. doi: 10.3389/fmicb.2018.01696. eCollection 2018.
4
Practical Advice on the One-Step Growth Curve.一步生长曲线的实用建议。
Methods Mol Biol. 2018;1681:41-47. doi: 10.1007/978-1-4939-7343-9_3.
5
Bacteriophages and development of nanomaterials for neural regeneration.噬菌体与用于神经再生的纳米材料的发展
Neural Regen Res. 2014 Nov 15;9(22):1955-8. doi: 10.4103/1673-5374.145371.
6
Amplification and purification of T4-like escherichia coli phages for phage therapy: from laboratory to pilot scale.用于噬菌体疗法的T4样大肠杆菌噬菌体的扩增与纯化:从实验室规模到中试规模
Appl Environ Microbiol. 2014 Feb;80(4):1469-76. doi: 10.1128/AEM.03357-13. Epub 2013 Dec 20.
7
A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.噬菌体疗法作为抗生素的替代品治疗细菌病原体的历史概述。
Virulence. 2014 Jan 1;5(1):226-35. doi: 10.4161/viru.25991. Epub 2013 Aug 13.
8
Cronobacter: an emerging opportunistic pathogen associated with neonatal meningitis, sepsis and necrotizing enterocolitis.克罗诺杆菌:一种与新生儿脑膜炎、败血症和坏死性小肠结肠炎相关的新兴机会致病菌。
J Perinatol. 2013 Aug;33(8):581-5. doi: 10.1038/jp.2013.26. Epub 2013 Mar 28.
9
Cronobacter sakazakii ST4 strains and neonatal meningitis, United States.美国阪崎肠杆菌ST4菌株与新生儿脑膜炎
Emerg Infect Dis. 2013 Jan;19(1):175-7. doi: 10.3201/eid1901.120649.
10
Bacteriophage electron microscopy.噬菌体电子显微镜技术。
Adv Virus Res. 2012;82:1-32. doi: 10.1016/B978-0-12-394621-8.00017-0.